SU-DHL-8 Cells
USD 395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Información general
| Descripción | SU-DHL-8 is a human diffuse large B-cell lymphoma (DLBCL) cell line derived from an adult patient. It represents the activated B-cell-like (ABC) subtype of DLBCL, which is characterized by constitutive activation of the NF-κB signaling pathway and typically exhibits poorer prognosis compared to the germinal center B-cell-like (GCB) subtype. Morphologically, the SU-DHL-8 cells grow as large, loosely adherent aggregates in suspension, consistent with B-cell lymphoma phenotypes. Molecular characterization reveals that SU-DHL-8 harbors mutations commonly associated with ABC-DLBCL, including alterations affecting the BCR and NF-κB signaling pathways. Genomic profiling through next-generation sequencing and expression analysis has identified elevated activity in pathways such as JAK/STAT and BCL2-associated anti-apoptotic signaling. The cell line is also part of several large-scale pharmacogenomic studies and cancer model repositories, where it has been used to explore drug sensitivities, particularly to kinase inhibitors and proteasome-targeting agents. These features make SU-DHL-8 a representative and valuable model for investigating the molecular pathogenesis and therapeutic vulnerabilities of ABC-type DLBCL. |
|---|---|
| Organismo | Human |
| Tejido | Pleural effusion |
| Enfermedad | Diffuse large B-cell lymphoma germinal center B-cell type |
| Sinónimos | SUDHL8, SUDHL-8, SuDHL 8, Stanford University-Diffuse Histiocytic Lymphoma-8, DHL-8, DHL8 |
Características
| Edad | 59 years |
|---|---|
| Género | Male |
| Origen étnico | Caucasian |
| Morfología | Lymphoblast-like |
| Tipo de célula | B lymphocyte |
| Propiedades de crecimiento | Suspension, single cells and small clusters |
Datos normativos
| Referencia | SU-DHL-8 (Cytion catalog number 305877) |
|---|---|
| Nivel de bioseguridad | 1 |
| NCBI_TaxID | 9606 |
| N.º de acceso de Cellosaurus | CVCL_2207 |
Datos biomoleculares
| Expresión de antígenos | Ig+; IgM-, IgG-, IgA-, IgD-, Lambda-, Kappa- |
|---|---|
| Perfil mutacional | Mutation: KMT2D, Simple, p.Pro648Thrfs*2 (c.1940dupC) (c.1940_1941insC), Heterozygous (Cosmic-CLP=1331038), TP53, Simple, p.Tyr234Asn (c.700T>A), Heterozygous (Cosmic-CLP=1331038), TP53, Simple, p.Arg249Gly (c.745A>G), Heterozygous (Cosmic-CLP=1331038) |
Manejo
| Medio de cultivo | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suplementos | Supplement the medium with 10% FBS |
| Reactivo de disociación | none |
| Tiempo de duplicación | ~48-72 hours |
| Densidad de siembra | 0.3-0.5 x 106 cells/ml |
| Renovación de fluidos | 2 to 3 times per week |
| Medio de congelación | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelación y cultivo de células |
|
| Atmósfera de incubación | 37°C, 5% CO2, humidified atmosphere. |
| Condiciones de envío | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condiciones de almacenamiento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Control de calidad y análisis molecular
| Esterilidad | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de análisis (CoA)
| Número de lote | Tipo de certificado | Fecha | Número de catálogo |
|---|---|---|---|
| 305877-301025 | Certificado de análisis | 05. Dec. 2025 | 305877 |
-
Related products
Related products
SU-DHL-4 CellsOrganismo Human Tejido Peritoneal effusion Enfermedad Diffuse large B-cell lymphoma USD 395.00*Células SU-DHL-1Organismo Humano Tejido Derrame pleural Enfermedad Linfoma anaplásico de células grandes, ALK-positivo USD 395.00*